BerGenBio ASA: Extraordinary General Meeting held
Bergen, Norway, 6 January 2022 – BerGenBio ASA (OSE:BGBIO) announces that an extraordinary general meeting in the Company was held on 6 January 2022. All proposals were resolved as presented in the notice convening the extraordinary general meeting distributed on 16 December 2022, as further set out in the minutes from the extraordinary general meeting attached hereto and available at https://www.bergenbio.com/investors/general- meetings/ -Ends- For further information, please contact: